The release of the snapshot containing the respective simulations can be found here:
https://github.com/Open-Systems-Pharmacology/Efavirenz-Midazolam-DDI/releases/tag/v1.2

The efavirenz-midazolam interaction was evaluated using two clinical DDI studies, one using single dose and one using one multiple dose administration of efavirenz ([Katzenmaier 2010](#4-references), [Mikus 2017](#4-references)).



| DataID | Enzyme | Perpetrator / victim  | Study design                                                 | Comment | Clinical study                    |
| ------ | ------ | --------------------- | ------------------------------------------------------------ | ------- | --------------------------------- |
| 2041   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po OD over 14 days<br />Midazolam: 3 mg po single dose on day 14 together with efavirenz dose |         | [Katzenmaier 2010](#4-references) |
| 2044   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po SD on day 1<br />Midazolam: 4 mg po single dose, 12 hours (**day 1**) after efavirenz dose |         | [Mikus 2017](#4-references)       |
| 2045   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po SD on day 1<br />Midazolam: 2 mg iv single dose, 18 hours (**day 1**) after efavirenz dose |         | [Mikus 2017](#4-references)       |
| 2047   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po SD on day 1<br />Midazolam: 4 mg po single dose, 132 hours (**day 6**) after efavirenz dose |         | [Mikus 2017](#4-references)       |
| 2048   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po SD on day 1<br />Midazolam: 2 mg iv single dose, 138 hours (**day 6**) after efavirenz dose |         | [Mikus 2017](#4-references)       |
| 2049   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po SD on day 1<br />Midazolam: 4 mg po single dose, 252 hours (**day 11**) after efavirenz dose |         | [Mikus 2017](#4-references)       |
| 2050   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po SD on day 1<br />Midazolam: 2 mg iv single dose, 258 hours (**day 11**) after efavirenz dose |         | [Mikus 2017](#4-references)       |
| 2051   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po SD on day 1<br />Midazolam: 4 mg po single dose, 372 hours (**day 16**) after efavirenz dose |         | [Mikus 2017](#4-references)       |
| 2052   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po SD on day 1<br />Midazolam: 2 mg iv single dose, 378 hours (**day 16**) after efavirenz dose |         | [Mikus 2017](#4-references)       |
| 2053   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po SD on day 1<br />Midazolam: 4 mg po single dose, 516 hours (***day 22**) after efavirenz dose |         | [Mikus 2017](#4-references)       |
| 2054   | CYP3A4 | Efavirenz / midazolam | Efavirenz: 400 mg po SD on day 1<br />Midazolam: 2 mg iv single dose, 522 hours (**day 22**) after efavirenz dose |         | [Mikus 2017](#4-references)       |

